1 |
Support current measures (and develop innovative new ones) to prevent future drug shortages at the national level |
2 |
Optimize and efficiently use supplies to reduce the likelihood and mitigate the effects of future shortages |
3 |
Develop explicit policies that give equal priority during a drug shortage to evidence-based use of chemotherapy agents whether patients are receiving treatment within or outside a clinical trial |
4 |
Create an improved, centralized clearinghouse for sharing information about drug availability and shortages |
5 |
Explore voluntary sharing of drugs at the state, regional, and national levels |
6 |
Develop a strategy for ongoing stakeholder engagement regarding managing drug shortages, with specific emphasis on patients and patient advocacy groups |